Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Mar 2026.
- Notable investors include Brad Peltz, David Petersen, GU Holdings, Provision Capital, University of Glasgow.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Entourage AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Entourage AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Entourage AI
Developer of AI-powered medical diagnostics software designed to support clinical decision-making and improve patient outcomes. The company's platform applies machine learning to multimodal clinical data, generates structured diagnostic insights, integrates into existing clinical workflows, and offers tools for monitoring performance and adapting models over time, enabling hospitals, diagnostic laboratories, and healthcare providers to achieve more accurate, consistent, and efficient diagnostic assessment at scale while reducing reliance on manual interpretation and lowering operational burden.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2025
- Website
- entourageai.com/
- Ownership
- Privately Held (backing)
Entourage AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Entourage AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Entourage AI in its N-PORT filings yet. We sweep new filings monthly.